Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - PIIS0140-6736(20)31483-5.pdf
Covid19-Sources
The problem with 'shielding' people from coronavirus? It's almost impossible | Coronavirus | The Guardian
The Coronavirus Is Never Going Away - The Atlantic
There may be no immunity against Covid-19, new Wuhan study suggests - TODAY
Getting a handle on asymptomatic SARS-CoV-2 infection | Scripps Research
Coronavirus: Why You Must Act Now | by Tomas Pueyo | Medium
The UK needs a sustainable strategy for COVID-19 - The Lancet
Corona: Was Deutschland von anderen Staaten lernen kann
Coronavirus: Should We Aim for Herd Immunity Like Sweden? | by Tomas Pueyo | Medium
Heterogene Bevölkerung entwickelt schneller Herdenimmunität | Max-Planck-Gesellschaft
The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries | Science
RKI - Coronavirus SARS-CoV-2 - COVID-19: Fallzahlen in Deutschland und weltweit
Coronavirus-Karte: Deutschlandweite Fallzahlen in Echtzeit | Tagesspiegel
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera | Science
Vierfeldertafel - DocCheck Flexikon
CoVariants
Social influence matters: We follow pandemic guidelines most when our close circle does
GitHub - Priesemann-Group/covid19_inference: Bayesian python toolbox for inference and forecast of the spread of the Coronavirus
Corona-Pandemie: Frühe Hotspots in Europa vorab auf Twitter erkennbar | heise online
COVID-19 Tracking & Tracing
Inferring collective dynamical states from widely unobserved systems | Nature Communications
Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions | Science
The challenges of containing SARS-CoV-2 via test-trace-and-isolate | Nature Communications
RKI - Coronavirus SARS-CoV-2 - Digitales Impfquotenmonitoring zur COVID-19-Impfung
(1) Startseite / Twitter
Die Wirkung der Maßnahmen gegen die Corona-Pandemie in Deutschland | Max-Planck-Gesellschaft
Florian Krammer auf Twitter: "1) So, this morning I promised a little tweetorial about variants and here we go. This will be from a vaccine/antibody point of view only, I won't comment on how infectious they are or if they are more pathogenic (I'll leave that to Boris Johnson 😉)." / Twitter